These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18560759)

  • 1. Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities.
    Abaraviciene SM; Lundquist I; Salehi A
    Cell Mol Life Sci; 2008 Jul; 65(14):2256-65. PubMed ID: 18560759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitate-induced beta-cell dysfunction is associated with excessive NO production and is reversed by thiazolidinedione-mediated inhibition of GPR40 transduction mechanisms.
    Meidute Abaraviciene S; Lundquist I; Galvanovskis J; Flodgren E; Olde B; Salehi A
    PLoS One; 2008 May; 3(5):e2182. PubMed ID: 18478115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt.
    Størling J; Binzer J; Andersson AK; Züllig RA; Tonnesen M; Lehmann R; Spinas GA; Sandler S; Billestrup N; Mandrup-Poulsen T
    Diabetologia; 2005 Oct; 48(10):2039-50. PubMed ID: 16132952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pharmacological inhibition of NADPH oxidase or iNOS on pro-inflammatory cytokine, palmitic acid or H2O2-induced mouse islet or clonal pancreatic β-cell dysfunction.
    Michalska M; Wolf G; Walther R; Newsholme P
    Biosci Rep; 2010 Dec; 30(6):445-53. PubMed ID: 20178457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5'-AMP-activated protein kinase modulation.
    Wu J; Wu JJ; Yang LJ; Wei LX; Zou DJ
    Endocrine; 2013 Aug; 44(1):87-98. PubMed ID: 23109223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor/factor VIIa signalling promotes cytokine-induced beta cell death and impairs glucose-stimulated insulin secretion from human pancreatic islets.
    Edén D; Siegbahn A; Mokhtari D
    Diabetologia; 2015 Nov; 58(11):2563-72. PubMed ID: 26271343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role and mechanism of rosiglitazone on the impairment of insulin secretion induced by free fatty acids on isolated rat islets.
    Tian JY; Li G; Gu YY; Zhang HL; Zhou WZ; Wang X; Zhu HD; Luo TH; Luo M
    Chin Med J (Engl); 2006 Apr; 119(7):574-80. PubMed ID: 16620699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of islet inducible nitric oxide synthase and inhibition of glucose-stimulated insulin release after long-term lipid infusion in the rat is counteracted by PACAP27.
    Qader SS; Jimenez-Feltström J; Ekelund M; Lundquist I; Salehi A
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1447-55. PubMed ID: 17264229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular signal-regulated kinase is essential for interleukin-1-induced and nuclear factor kappaB-mediated gene expression in insulin-producing INS-1E cells.
    Larsen L; Størling J; Darville M; Eizirik DL; Bonny C; Billestrup N; Mandrup-Poulsen T
    Diabetologia; 2005 Dec; 48(12):2582-90. PubMed ID: 16283237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone attenuates fatty acid-induced oxidative stress and apoptosis in pancreatic beta-cells.
    Saitoh Y; Chun-ping C; Noma K; Ueno H; Mizuta M; Nakazato M
    Diabetes Obes Metab; 2008 Jul; 10(7):564-73. PubMed ID: 17593232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal nitric oxide synthase protects the pancreatic beta cell from glucolipotoxicity-induced endoplasmic reticulum stress and apoptosis.
    Bachar E; Ariav Y; Cerasi E; Kaiser N; Leibowitz G
    Diabetologia; 2010 Oct; 53(10):2177-87. PubMed ID: 20596694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Per-Arnt-Sim Kinase and extracellular-regulated kinases-1/2 in palmitate inhibition of insulin gene expression in pancreatic beta-cells.
    Fontés G; Semache M; Hagman DK; Tremblay C; Shah R; Rhodes CJ; Rutter J; Poitout V
    Diabetes; 2009 Sep; 58(9):2048-58. PubMed ID: 19502418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BLX-1002, a novel thiazolidinedione with no PPAR affinity, stimulates AMP-activated protein kinase activity, raises cytosolic Ca2+, and enhances glucose-stimulated insulin secretion in a PI3K-dependent manner.
    Zhang F; Dey D; Bränström R; Forsberg L; Lu M; Zhang Q; Sjöholm A
    Am J Physiol Cell Physiol; 2009 Feb; 296(2):C346-54. PubMed ID: 19052259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.
    Chang PC; Chen TH; Chang CJ; Hou CC; Chan P; Lee HM
    Kidney Int; 2004 May; 65(5):1664-75. PubMed ID: 15086905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of MKK3 and p38 MAPK in cytokine-induced death of insulin-producing cells.
    Makeeva N; Myers JW; Welsh N
    Biochem J; 2006 Jan; 393(Pt 1):129-39. PubMed ID: 16097952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolidinediones protect mouse pancreatic β-cells directly from cytokine-induced cytotoxicity through PPARγ-dependent mechanisms.
    Wang AP; Li X; Zheng Y; Liu BL; Huang G; Yan X; Liu Z; Zhou Z
    Acta Diabetol; 2013 Apr; 50(2):163-73. PubMed ID: 21153483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational control of inducible nitric oxide synthase by p38 MAPK in islet β-cells.
    Nishiki Y; Adewola A; Hatanaka M; Templin AT; Maier B; Mirmira RG
    Mol Endocrinol; 2013 Feb; 27(2):336-49. PubMed ID: 23250488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological concentrations of interleukin-6 directly promote insulin secretion, signal transduction, nitric oxide release, and redox status in a clonal pancreatic β-cell line and mouse islets.
    da Silva Krause M; Bittencourt A; Homem de Bittencourt PI; McClenaghan NH; Flatt PR; Murphy C; Newsholme P
    J Endocrinol; 2012 Sep; 214(3):301-11. PubMed ID: 22761278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion.
    Lupi R; Del Guerra S; Marselli L; Bugliani M; Boggi U; Mosca F; Marchetti P; Del Prato S
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E560-7. PubMed ID: 14625208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic β-cell dysfunction, expression of iNOS and the effect of phosphodiesterase inhibitors in human pancreatic islets of type 2 diabetes.
    Muhammed SJ; Lundquist I; Salehi A
    Diabetes Obes Metab; 2012 Nov; 14(11):1010-9. PubMed ID: 22687049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.